Literature DB >> 7410215

Antibiotic Bu-2545, a new member of the celesticetin-lincomycin class.

M Hanada, M Tsunakawa, K Tomita, H Tsukiura, H Kawaguchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7410215     DOI： 10.7164/antibiotics.33.751

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  5 in total

1.  Characterization of Enzymes Catalyzing Transformations of Cysteine S-Conjugated Intermediates in the Lincosamide Biosynthetic Pathway.

Authors:  Richiro Ushimaru; Chia-I Lin; Eita Sasaki; Hung-Wen Liu
Journal:  Chembiochem       Date:  2016-07-19       Impact factor: 3.164

2.  In vitro characterization of LmbK and LmbO: identification of GDP-D-erythro-α-D-gluco-octose as a key intermediate in lincomycin A biosynthesis.

Authors:  Chia-I Lin; Eita Sasaki; Aoshu Zhong; Hung-wen Liu
Journal:  J Am Chem Soc       Date:  2014-01-10       Impact factor: 15.419

3.  Studies of lincosamide formation complete the biosynthetic pathway for lincomycin A.

Authors:  Shao-An Wang; Chia-I Lin; Jiawei Zhang; Richiro Ushimaru; Eita Sasaki; Hung-Wen Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-21       Impact factor: 11.205

Review 4.  The biosynthesis of nitrogen-, sulfur-, and high-carbon chain-containing sugars.

Authors:  Chia-I Lin; Reid M McCarty; Hung-wen Liu
Journal:  Chem Soc Rev       Date:  2013-01-25       Impact factor: 54.564

5.  Elucidation of salicylate attachment in celesticetin biosynthesis opens the door to create a library of more efficient hybrid lincosamide antibiotics.

Authors:  S Kadlcik; Z Kamenik; D Vasek; M Nedved; J Janata
Journal:  Chem Sci       Date:  2017-03-23       Impact factor: 9.825
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.